venturebeat
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during each handoff. A shocking 90% to 95% of drug discovery projects reportedly fail — one of the highest failure rates of any industry. A single successful drug can take over a dozen years and up to $1 billion from initial discovery to patient distribution, according to published reports. Generative AI is being used to solve some of the challenges, but Stanford researchers have moved the ball forward with agentic AI. A team led by James Zou, associate professor of Biomedical Data Science at Stanford University, has deployed thousands autonomous AI "scientist" agents in a virtual biotec [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

venturebeat
Frontier models are failing one in three production attempts — and getting harder to audit

AI agents are now embedded in real enterprise workflows, and they're still failing roughly one in three attempts on structured benchmarks. That gap between capability and reliability is the defin [...]

Match Score: 132.34

venturebeat
98% of market researchers use AI daily, but 4 in 10 say it makes errors — revealing a major trust problem

Market researchers have embraced artificial intelligence at a staggering pace, with 98% of professionals now incorporating AI tools into their work and 72% using them daily or more frequently, accordi [...]

Match Score: 74.19

venturebeat
Is agentic AI ready to reshape Global Business Services?

Presented by EdgeVerveBefore addressing Global Business Services (GBS), let’s take a step back. Can agentic AI, the type of AI able to take goal-driven action, transform not just GBS but any kind of [...]

Match Score: 67.93

venturebeat
Stanford is running 37,000 AI agents as a virtual biotech — and one of its drug designs got independently confirmed by Merck

For developers, the operating assumption has been one engineer, one agent — the model Claude Code and similar tools. At VB Transform 2026, James Zou, associate professor of biomedical data science a [...]

Match Score: 63.56

Destination
The new Warner Bros. and Discovery Global would like you to forget Warner Bros. Discovery

Earlier this summer Engadget covered the news that Warner Bros. Discovery would split into two giant media companies. Today the conglomerate announced the names for the restructured entities.<br /& [...]

Match Score: 56.21

venturebeat
Agentic AI security breaches are coming: 7 ways to make sure it's not your firm

AI agents – task-specific models designed to operate autonomously or semi-autonomously given instructions — are being widely implemented across enterprises (up to 79% of all surveyed for a PwC rep [...]

Match Score: 55.87

venturebeat
TTT-Discover optimizes GPU kernels 2x faster than human experts — by training during inference

Researchers from Stanford, Nvidia, and Together AI have developed a new technique that can discover new solutions to very complex problems. For example, they managed to optimize a critical GPU kernel [...]

Match Score: 54.94

venturebeat
Four AI agents coordinating in real time outperformed Claude Opus 4.8 on enterprise coding tasks

As enterprise codebases grow, AI agents tasked with analyzing them are buckling under the weight of long-horizon tasks that require multiple interactions and tool calls. Dividing the work among a team [...]

Match Score: 54.67

thenextweb
Chai Discovery raises $400M at $3.8bn as AI drug discovery moves from promise to deployment

Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fas [...]

Match Score: 53.01